Literature DB >> 10467981

Small GTPases in lymphocyte biology: Rho proteins take center stage.

S Henning1, S Cleverley.   

Abstract

Almost a decade ago, the small GTPase Ras was shown to be activated in response to antigen receptor triggering in T cells. Since then, Ras has been further characterized as a central molecule for the regulation of signal transduction pathways in lymphocytes. However, over the last couple of years, its exclusive role in lymphocyte biology has been challenged by the emergence of its relatives of the Rho family. Today it is well established that Rho GTPases act as unique molecular switches at several critical checkpoints in lymphocyte development and function. Additionally, a new and critical concept in GTPase signaling has taken shape over the last couple of years in that small GTPases are able to regulate quite diverse cellular processes in the immune response by linking to multiple biochemical effector pathways.

Mesh:

Substances:

Year:  1999        PMID: 10467981     DOI: 10.1007/BF02786505

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  59 in total

1.  The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors.

Authors:  A J Ridley; A Hall
Journal:  Cell       Date:  1992-08-07       Impact factor: 41.582

2.  Profound block in thymocyte development in mice lacking p56lck.

Authors:  T J Molina; K Kishihara; D P Siderovski; W van Ewijk; A Narendran; E Timms; A Wakeham; C J Paige; K U Hartmann; A Veillette
Journal:  Nature       Date:  1992-05-14       Impact factor: 49.962

3.  Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok.

Authors:  Y Yamanashi; D Baltimore
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

Review 4.  Views on Vav.

Authors:  T L Collins; M Deckert; A Altman
Journal:  Immunol Today       Date:  1997-05

Review 5.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

6.  Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.

Authors:  P Crespo; K E Schuebel; A A Ostrom; J S Gutkind; X R Bustelo
Journal:  Nature       Date:  1997-01-09       Impact factor: 49.962

7.  Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav.

Authors:  A Tarakhovsky; M Turner; S Schaal; P J Mee; L P Duddy; K Rajewsky; V L Tybulewicz
Journal:  Nature       Date:  1995-03-30       Impact factor: 49.962

8.  An activated lck transgene promotes thymocyte development in RAG-1 mutant mice.

Authors:  P Mombaerts; S J Anderson; R M Perlmutter; T W Mak; S Tonegawa
Journal:  Immunity       Date:  1994-07       Impact factor: 31.745

9.  Distinct Ras effector pathways are involved in Fc epsilon R1 regulation of the transcriptional activity of Elk-1 and NFAT in mast cells.

Authors:  H Turner; D A Cantrell
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

10.  Involvement of p21ras distinguishes positive and negative selection in thymocytes.

Authors:  K A Swan; J Alberola-Ila; J A Gross; M W Appleby; K A Forbush; J F Thomas; R M Perlmutter
Journal:  EMBO J       Date:  1995-01-16       Impact factor: 11.598

View more
  2 in total

Review 1.  Rho GTPase effectors and NAD metabolism in cancer immune suppression.

Authors:  Mahmoud Chaker; Audrey Minden; Suzie Chen; Robert H Weiss; Eduardo N Chini; Amit Mahipal; Asfar S Azmi
Journal:  Expert Opin Ther Targets       Date:  2017-12-10       Impact factor: 6.902

2.  Wiskott Aldrich syndrome protein (WASP) and N-WASP are critical for T cell development.

Authors:  Vinicius Cotta-de-Almeida; Lisa Westerberg; Michel H Maillard; Dilek Onaldi; Heather Wachtel; Parool Meelu; Ung-il Chung; Ramnik Xavier; Frederick W Alt; Scott B Snapper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.